HOGA1

HOGA1
Available structures
PDB	Ortholog search: PDBe RCSB
List of PDB id codes
	3S5N, 3S5O
Identifiers
Aliases	HOGA1, C10orf65, DHDPS2, DHDPSL, HP3, NPL2, 4-hydroxy-2-oxoglutarate aldolase 1
External IDs	OMIM: 613597 MGI: 1914682 HomoloGene: 12130 GeneCards: HOGA1
Gene location (Human)
Chr.	Chromosome 10 (human)[1]
End	97,612,802 bp[1]
Gene location (Mouse)
Chr.	Chromosome 19 (mouse)[2]
End	42,070,953 bp[2]
Gene ontology
Molecular function	• catalytic activity; • protein homodimerization activity; • lyase activity; • 4-hydroxy-2-oxoglutarate aldolase activity; • GO:0001948 protein binding;
Cellular component	• mitochondrion; • mitochondrial matrix;
Biological process	• metabolism; • pyruvate biosynthetic process; • 4-hydroxyproline catabolic process; • glyoxylate catabolic process; • oxalate metabolic process; • glyoxylate metabolic process;
	Sources:Amigo / QuickGO
Orthologs
	112817
	67432
	ENSG00000241935
	ENSMUSG00000025176
	Q86XE5
	Q9DCU9
	NM_138413; NM_001134670
	NM_026152
	NP_001128142; NP_612422
	NP_080428
	Wikidata
View/Edit Human	View/Edit Mouse

4-Hydroxy-2-oxoglutarate aldolase, mitochondrial (HOGA1) also known as dihydrodipicolinate synthase-like (DHDPSL) is an enzyme that in humans is encoded by the HOGA1 gene. The protein is one of the enzymes (4-hydroxy-2-oxoglutarate aldolase) involved in metabolism of hydroxyproline to glyoxylate. The enzyme overactivity can form excessive glyoxylate from hydroxyproline. Glyoxylate is catabolised to oxalate, resulting in excess excretion of oxalate in urine, predisposing to oxalate stone; a condition known as primary hyperoxaluria type III.[5]

References

GRCh38: Ensembl release 89: ENSG00000241935 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000025176 - Ensembl, May 2017
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Belostotsky R, Seboun E, Idelson GH, Milliner DS, Becker-Cohen R, Rinat C, Monico CG, Feinstein S, Ben-Shalom E, Magen D, Weissman I, Charon C, Frishberg Y (September 2010). "Mutations in DHDPSL are responsible for primary hyperoxaluria type III". American Journal of Human Genetics. 87 (3): 392–9. doi:10.1016/j.ajhg.2010.07.023. PMC 2933339. PMID 20797690.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000241935 - Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000025176 - Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[pmid20797690-5] Belostotsky R, Seboun E, Idelson GH, Milliner DS, Becker-Cohen R, Rinat C, Monico CG, Feinstein S, Ben-Shalom E, Magen D, Weissman I, Charon C, Frishberg Y (September 2010). "Mutations in DHDPSL are responsible for primary hyperoxaluria type III". American Journal of Human Genetics. 87 (3): 392–9. doi:10.1016/j.ajhg.2010.07.023. PMC 2933339. PMID 20797690.